https://cordis.europa.eu/project/id/753527/fr
The ATP-P2X7R axis: a target for drug-refractory epilepsy | EpiPur | Projet | Fiche descriptive |...
Current epilepsy therapies, based on mediating excitation or inhibition have no impact on disease progression and are ineffective in over 30% of patients,...
https://www.cordis.europa.eu/project/id/753527/es
The ATP-P2X7R axis: a target for drug-refractory epilepsy | EpiPur | Proyecto | Ficha informativa |...
Current epilepsy therapies, based on mediating excitation or inhibition have no impact on disease progression and are ineffective in over 30% of patients,...
https://www.cordis.europa.eu/project/id/753527/fr
The ATP-P2X7R axis: a target for drug-refractory epilepsy | EpiPur | Projet | Fiche descriptive |...
Current epilepsy therapies, based on mediating excitation or inhibition have no impact on disease progression and are ineffective in over 30% of patients,...
https://cordis.europa.eu/project/id/753527
The ATP-P2X7R axis: a target for drug-refractory epilepsy | EpiPur | Project | Fact Sheet | H2020 |...
Current epilepsy therapies, based on mediating excitation or inhibition have no impact on disease progression and are ineffective in over 30% of patients,...